Respirics
Raleigh
About Respirics
Respirics is an inhalation drug products company focusing on the development and commercialization of therapeutic products using the company's proprietary, customizable Acu-Breathe™ dry powder inhalers (DPIs). The company's strategy is to develop a suite of inhalation products for asthma and COPD, and to enter licensing and co-development programs with large or specialty pharmaceutical companies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.6M
- Last round: Series Unknown (Aug 2010)
- Website: respirics.com
- Phone: +1 919-789-4220
Industries & Categories
Biotechnology, Developer Platform, Therapeutics
Canonical: https://fsome.com/organization/respirics-434861 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.